Levine D, Tilton R C, Parry M F, Klenk R, Morelli A, Hofreuter N
New England Pediatrics, Stamford, CT 06902.
Pediatrics. 1994 Dec;94(6 Pt 1):892-4.
To assess the reliability of the Monolert test, a new enzyme-linked immunosorbent assay for the diagnosis of acute infectious mononucleosis (IM).
A retrospective laboratory and clinical analysis of 38 children diagnosed with acute IM.
A suburban pediatric practice in Connecticut.
Thirty-eight children (ages 18 months to 17 years) who were diagnosed with acute IM using the Monolert test during the period October 1992 to August 1993.
Eighty-three percent of these children had no evidence of Epstein-Barr virus infection on subsequent investigation. The false positive results of the Monolert test could not be explained on the basis of elevated antibody titers to either cytomegalovirus or Borrelia burgdorferi.
Monolert is a poor screening test and is of little apparent value as a diagnostic test for acute Epstein-Barr virus infection in pediatric patients.
评估新型酶联免疫吸附试验Monolert检测在诊断急性传染性单核细胞增多症(IM)中的可靠性。
对38例诊断为急性IM的儿童进行回顾性实验室和临床分析。
康涅狄格州的一家郊区儿科诊所。
1992年10月至1993年8月期间使用Monolert检测诊断为急性IM的38名儿童(年龄18个月至17岁)。
这些儿童中83%在后续检查中无EB病毒感染证据。Monolert检测的假阳性结果无法用巨细胞病毒或伯氏疏螺旋体抗体滴度升高来解释。
Monolert是一种较差的筛查试验,作为儿科患者急性EB病毒感染的诊断试验,其价值不大。